The Riverside Company has generated a money multiple of 4.3x and a gross IRR of 60% on the sale of its Spanish pharmaceuticals business Euromed Botanicals to Frankfurt-listed Dermapharm Holding, Unquote understands.
GP said the deal will facilitate further investment in the development of Nordic Capital
KKR, Index Ventures, Ares and Alven Capital have each sold 50% of their shares in the company
In his new role, Piacentini will support KKR's technology, media and telecoms investment activities
Transaction sees the management team retain a majority stake in consultancy Epsa